Skip to contentE
Enveric Biosciences, Inc.
E
ENVBEnveric Biosciences, Inc. Q2 2016 · 10-Q
Revenue$6.69M$6.69Mno prior Q2 2015 on file Net Income-$1.21M-$1.21Mno prior Q2 2015 on file EPS Diluted-$0.09-$0.09no prior Q2 2015 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,399,489— Margins · derivedGross margin22.7%
Operating margin-14.0%
Net margin-18.1%
ended Jun 30, 2016 · filed Aug 12, 2016 · 43 d after period end